The company will use the cash to increase production capacity of its recently launched Peregrine and Merlin systems; develop an international sales and marketing force; and help the company develop a protein-folding/-unfolding chip for drug discovery and QA/QC applications, and a "virtual" 2D chip to "replace" 2D gels.
Major participants in the financing round included existing investors FF&P Private Equity Limited, which led the round; Imperial Innovations; and NPI Ventures; as well as new investors London Technology Fund and Sitka Health Fund.
Deltadot, based in